Drugs

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Drugs
Dec 29, 2024, 10:00 | Drugs
Giannis Mountzios: 10 exciting compounds that will shape lung cancer in 2025
Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air force…
Dec 28, 2024, 18:13 | Drugs
Ever wondered how cancer drugs are approved?
FDA Oncology shared a post on X: “Ever wondered how cancer drugs are approved? Learn…
Dec 28, 2024, 18:09 | Drugs
Rami Manochakian: FDA approved subcutaneous Nivolumab for Solid Tumors
  Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared a post on X: "U.S FDA…
Dec 28, 2024, 15:46 | Drugs
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 28, 2024, 09:19 | Drugs
UTSW Radiation Oncology Department has imaged its first patient using Reflexion PET with the Ga68-PSMA-11 tracer
The Radiation Oncology team at UT Southwestern imaged its first patient using Reflexion PET with…
Dec 27, 2024, 10:48 | Drugs
Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…
Dec 24, 2024, 14:29 | Drugs
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: “Advanced urothelial carcinoma…
Dec 24, 2024, 07:26 | Drugs
FDA Approves Generic Nilotinib: Expanding Access to Chronic Myeloid Leukemia Treatment
Nitolinib, developed by Hetero under a sublicense from the Medicines Patent Pool (MPP), is the…
Dec 23, 2024, 11:55 | Drugs
Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction
Talha Badar shared on X: “Brief overview of venetoclax+azacitidine for elderly AML ineligible for intensive…
Dec 21, 2024, 10:38 | Drugs
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024
Hanna Foster, Scientific Product Sales Manager at Quadratech DiagnosticsLtd, shared on LinkedIn: “Market cap and…
All: 441 Posts: 1 - 10
Special Coverage